Evidence map›Paper›PMID 40155963›Full record

ArticleCardiovascular ultrasound2025

The role of left atrio-ventricular coupling index and left atrial ejection fraction in predicting onset of atrial fibrillation and adverse cardiac events in hypertrophic cardiomyopathy.

Parisi Francesca, La Franca Eluisa, Pistelli Lorenzo, Gentile Giovanni, Bellavia Diego, Nuzzi Vincenzo, Manca Paolo, Massimiliano Mulè, Zito Concetta, Di Bella Gianluca and 3 more

Abstract read
In one paragraph

Article in Cardiovascular ultrasound, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Parisi FrancescaClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy. fparisi@ismett.edu.
La Franca EluisaClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Pistelli LorenzoDepartment of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.
Gentile GiovanniRadiology Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Bellavia DiegoDepartment of Research, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Nuzzi VincenzoClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Manca PaoloClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Massimiliano MulèClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Zito ConcettaDepartment of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.
Di Bella GianlucaDepartment of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.
Scipione CarerjDepartment of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.
Cipriani ManlioClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.
Francesco F FaletraClinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT), IRCCS, Palermo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral predictors of atrial fibrillation (AF) onset in patients with hypertrophic cardiomyopathy (HCM) have been proposed, however, all of them showed limited accuracy. This study aims to assess the role of new echographic parameters in predicting AF onset and major adverse cardiovascular outcomes (cardiovascular death or heart transplantation).

methodsClinical and imaging data from 141 patients with HCM and without a history of AF were retrospectively analyzed over a 5-year period. Patients who developed AF during the study were compared to those who did not. The analysis focused on key atrial parameters, including the Left Atrial Contraction Index (LACI) and Left Atrial Ejection Fraction (LAEF). LACI was defined as the ratio of left atrial end-diastolic volume to left ventricular end-diastolic volume. Echocardiographic measurements were standardized using cardiac magnetic resonance (CMR) as the reference. Regarding statistical analysis, each significant continuous variable was categorized by identifying a cut-off value using the Youden index. Independent associations with outcomes and cumulative survival were assessed using Cox regression analysis.

resultsThirty-five patients developed AF, at a mean time of 4 years. The HCM-AF group had significantly higher values of LACI, left atrial diameter (LAD), and left atrial minimum volume (LAVmin). A LACI > 43% on echocardiography and LACI > 44% on CMR showed the best performance in identifying patients at risk for AF. In multivariate analysis, an echocardiographic LAEF < 43% was independently associated with the occurrence of AF (HR 2.9, 95% CI: 1.2-6.9). Additionally, a LAD > 40.5 mm was independently associated with AF onset, with a hazard ratio of 2.5 (95% CI 1.1-5.5). Eleven patients experienced the composite outcome of cardiovascular death or heart transplant, and a LACI > 60% was associated with this outcome.

conclusionIn patients with HCM, both LACI and LAEF were significantly associated with the occurrence of AF over a 4-year period, demonstrating higher sensitivity and specificity compared to other parameters. A LACI > 60% was also found to be associated with cardiovascular death or heart transplant in this population.

Indexed as

Atrial FibrillationAtrial Function, LeftCardiomyopathy, HypertrophicEchocardiographyHeart AtriaHeart VentriclesStroke VolumeVentricular Function, LeftAdultFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesAdverse outcomeAtrial fibrillationHypertrophic cardiomyopathyImagingPredictor

Identifiers

PMID40155963
PMCPMC11951586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.